Oxford BioDynamics OXBOF Stock
Oxford BioDynamics Price Chart
Oxford BioDynamics OXBOF Financial and Trading Overview
| Oxford BioDynamics stock price | 0.0030 USD |
| Previous Close | 0.003 USD |
| Open | 0.0052 USD |
| Bid | 0.002 USD x 1000000 |
| Ask | 1 USD x 30000 |
| Day's Range | 0.005 - 0.0052 USD |
| 52 Week Range | 0.0014 - 0.01 USD |
| Volume | 101K USD |
| Avg. Volume | 7.99K USD |
| Market Cap | 12.87M USD |
| Beta (5Y Monthly) | -0.191 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OXBOF Valuation Measures
| Enterprise Value | 16.59M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.75592 |
| Price/Book (mrq) | 2.2235894 |
| Enterprise Value/Revenue | 15.152 |
| Enterprise Value/EBITDA | -1.616 |
Trading Information
Oxford BioDynamics Stock Price History
| Beta (5Y Monthly) | -0.191 |
| 52-Week Change | -25.00000000000000000000000000000000% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.0014 USD |
| 50-Day Moving Average | 0.003138 USD |
| 200-Day Moving Average | 0.0047095 USD |
OXBOF Share Statistics
| Avg. Volume (3 month) | 7.99K USD |
| Avg. Daily Volume (10-Days) | 25 USD |
| Shares Outstanding | 4.29B |
| Float | 3.06B |
| Short Ratio | N/A |
| % Held by Insiders | 9.79% |
| % Held by Institutions | 41.16% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -958.85% |
| Gross Margin | 47.67% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.52% |
| Return on Equity (ttm) | -407.48% |
Income Statement
| Revenue (ttm) | 1.1M USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 64.40% |
| Gross Profit (ttm) | 522K USD |
| EBITDA | -10266000 USD |
| Net Income Avi to Common (ttm) | -11153000 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.39M USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 5.11M USD |
| Total Debt/Equity (mrq) | 457.98 USD |
| Current Ratio (mrq) | 0.875 |
| Book Value Per Share (mrq) | 0.00134917 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -7573000 USD |
| Levered Free Cash Flow (ttm) | -4323000 USD |
Profile of Oxford BioDynamics
| Country | United States |
| State | N/A |
| City | Oxford |
| Address | 3140 Rowan Place |
| ZIP | OX4 2WB |
| Phone | 44 1865 518 910 |
| Website | https://www.oxfordbiodynamics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 41 |
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Q&A For Oxford BioDynamics Stock
What is a current OXBOF stock price?
Oxford BioDynamics OXBOF stock price today per share is 0.0030 USD.
How to purchase Oxford BioDynamics stock?
You can buy OXBOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oxford BioDynamics?
The stock symbol or ticker of Oxford BioDynamics is OXBOF.
Which industry does the Oxford BioDynamics company belong to?
The Oxford BioDynamics industry is Diagnostics & Research.
How many shares does Oxford BioDynamics have in circulation?
The max supply of Oxford BioDynamics shares is 4.29B.
What is Oxford BioDynamics Price to Earnings Ratio (PE Ratio)?
Oxford BioDynamics PE Ratio is now.
What was Oxford BioDynamics earnings per share over the trailing 12 months (TTM)?
Oxford BioDynamics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Oxford BioDynamics company belong to?
The Oxford BioDynamics sector is Healthcare.